| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $189.4M | +8.3% |
| SG&A Expense | $72.2M | +20.7% |
| Operating Income | -$261.6M | -11.4% |
| Interest Expense | $5.8M | +28.4% |
| Pre-tax Income | -$246.8M | -14.6% |
| Income Tax | $468K | +14.7% |
| Net Income | -$247.3M | -14.6% |
| EPS (Basic) | -$3.07 | +5.2% |
| EPS (Diluted) | -$3.07 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.1M | +49.2% |
| Short-term Investments | $372.7M | +7.6% |
| Current Assets | $495.9M | +14.3% |
| Total Assets | $551.3M | +13.0% |
| Current Liabilities | $62.4M | +54.2% |
| Long-term Debt | $46.4M | +3.5% |
| Total Liabilities | $135.5M | +19.7% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$192.3M | -3.7% |
| Investing Cash Flow | -$23.8M | -124.5% |
| Financing Cash Flow | $252.4M | +1450.1% |
| +5.2% |
| Stockholders' Equity |
| $415.8M |
| +11.0% |